In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sividon Diagnostics GmbH

Division of Myriad Genetics Inc.

Latest From Sividon Diagnostics GmbH

Device/Diagnostics Quarterly Deal Statistics, Q2 2016

Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.

Deals Market Intelligence
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Myriad Genetics Inc.
  • Senior Management
  • Christoph Petry, PhD, CEO
    Georg Kox, PhD, Managing Dir. & CFO
    Ralf Kronenwett, MD, PhD, CSO & CMO
    Kerstin Bohmann, PhD, COO
  • Contact Info
  • Sividon Diagnostics GmbH
    Phone: 221 669 561 00
    Nattermannallee 1 - S19
    Cologne, 50829